Biochips Market Research Report Information by Type (DNA Chips, Lab-On-A-Chip, and Protein Chips), By Technology (Microarrays and Microfluidics), by End-User (Biotechnology and Pharmaceutical Companies, Hospitals, and Diagnostics Centers), And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Biochips Market, by Type

6.1 Introduction

6.2 DNA chips

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3 Lab-On-A-Chip

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.4 Protein Chips

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.5 Cell Arrays

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.6 Tissue Arrays

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 7. Global Biochips Market, by Technology

7.1 Introduction

7.2 Microarrays

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3 Microfluidics

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 8. Global Biochips Market, by End User

8.1 Introduction

8.2 Biotechnology and Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.3 Hospitals and Diagnostics Centers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.4 Academic & Research Institutes

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.5 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 9. Global Biochips Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Perkinelmer, Inc.

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Fluidigm Corporation

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Agilent Technologies, Inc.

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Abbott Laboratories

11.4.1 Company Overview

11.4.2 Type Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Bio-Rad Laboratories Inc.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Cepheid Inc.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Illumina, Inc.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 GE Healthcare

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Thermo Fisher Scientific

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Roche Diagnostics

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Biochips Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Biochips Market Synopsis, 2023-2032

Table 2 Global Biochips Market Estimates and Forecast, 2023-2032

(USD Million)

Table 3 Global Biochips Market, by Region, 2023-2032 (USD Million)

Table 4 Global Biochips Market, by Type, 2023-2032 (USD Million)

Table 5 Global Biochips Market, by Technology, 2023-2032(USD Million)

Table 6 Global Biochips Market, by End User, 2023-2032 (USD Million)

Table 7 North America: Biochips Market, by Type, 2023-2032 (USD Million)

Table 8 North America: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 9 North America: Biochips Market, by End User, 2023-2032 (USD Million)

Table 10 US: Biochips Market, by Type, 2023-2032 (USD Million)

Table 11 US: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 12 US: Biochips Market, by End User, 2023-2032 (USD Million)

Table 13 Canada: Biochips Market,by Type, 2023-2032 (USD Million)

Table 14 Canada: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 15 Canada: Biochips Market, by End User, 2023-2032 (USD Million)

Table 16 South America: Biochips Market, by Type, 2023-2032 (USD

Million)

Table 17 South America: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 18 South America: Biochips Market, by End User, 2023-2032 (USD Million)

Table 19 Europe: Biochips Market, by Type, 2023-2032 (USD Million)

Table 20 Europe: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 21 Europe: Biochips Market, by End User, 2023-2032 (USD Million)

Table 22 Western Europe: Biochips Market, by Type, 2023-2032 (USD Million)

Table 23 Western Europe: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 24 Western Europe: Biochips Market, by End User, 2023-2032 (USD Million)

Table 25 Eastern Europe: Biochips Market, by Type, 2023-2032 (USD Million)

Table 26 Eastern Europe: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 27 Eastern Europe: Biochips Market, by End User, 2023-2032(USD Million)

Table 28 Asia-Pacific: Biochips Market, by Type, 2023-2032 (USD Million)

Table 29 Asia-Pacific: Biochips Market, by Technology, 2023-2032 (USD Million)

Table 30 Asia-Pacific: Biochips Market, by End User, 2023-2032 (USD Million)

Table 31 Middle East & Africa: Biochips Market, by Type, 2023-2032 (USD Million)

Table 32 Middle East & Africa: Biochips Market, byTechnology, 2023-2032 (USD Million)

Table 33 Middle East & Africa: Biochips Market, by End User, 2023-2032 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Biochips Market

Figure 3 Segmentation Market Dynamics for Global Biochips Market

Figure 4 Global Biochips Market Share, by Type, 2020

Figure 5 Global Biochips Market Share, by Technology, 2020

Figure 6 Global Biochips Market Share, by End User, 2020

Figure 7 Global Biochips Market Share, by Region, 2020

Figure 8 North America: Biochips Market Share, by Country, 2020

Figure 9 Europe: Biochips Market Share, by Country, 2020

Figure 10 Asia-Pacific: Biochips Market Share, by Country, 2020

Figure 11 Middle East & Africa: Biochips Market Share, by Country, 2020

Figure 12 Global Biochips Market: Company Share Analysis, 2020 (%)

Figure 13 Perkinelmer, Inc. : Key Financials

Figure 14 Perkinelmer, Inc. : Segmental Revenue

Figure 15 Perkinelmer, Inc. : Geographical Revenue

Figure 16 Fluidigm Corporation : Key Financials

Figure 17 Fluidigm Corporation : Segmental Revenue

Figure 18 Fluidigm Corporation : Geographical Revenue

Figure 19 Agilent Technologies, Inc. : Key Financials

Figure 20 Agilent Technologies, Inc. : Segmental Revenue

Figure 21 Agilent Technologies, Inc. : Geographical Revenue

Figure 22 Abbott Laboratories : Key Financials

Figure 23 Abbott Laboratories : Segmental Revenue

Figure 24 Abbott Laboratories : Geographical Revenue

Figure 25 Bio-Rad Laboratories Inc. : Key Financials

Figure 26 Bio-Rad Laboratories Inc. : Segmental Revenue

Figure 27 Bio-Rad Laboratories Inc. . Geographical Revenue

Figure 28 Cepheid Inc. : Key Financials

Figure 29 Cepheid Inc. : Segmental Revenue

Figure 30 Cepheid Inc. : Geographical Revenue

Figure 31 Illumina, Inc. : Key Financials

Figure 32 Illumina, Inc. : Segmental Revenue

Figure 33 Illumina, Inc. : Geographical Revenue

Figure 34 Thermo Fisher Scientific : Key Financials

Figure 35 Thermo Fisher Scientific : Segmental Revenue

Figure 36 Thermo Fisher Scientific : Geographical Revenue

Figure 37 Roche Diagnostics : Key Financials

Figure 38 Roche Diagnostics : Segmental Revenue

Figure 39 Roche Diagnostics : Geographical Revenue